Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

543 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Primary follicular lymphoma of the testis in children and adolescents.
Lones MA, Raphael M, McCarthy K, Wotherspoon A, Terrier-Lacombe MJ, Ramsay AD, Maclennan K, Cairo MS, Gerrard M, Michon J, Patte C, Pinkerton R, Sender L, Auperin A, Sposto R, Weston C, Heerema NA, Sanger WG, von Allmen D, Perkins SL. Lones MA, et al. Among authors: michon j. J Pediatr Hematol Oncol. 2012 Jan;34(1):68-71. doi: 10.1097/MPH.0b013e31820e4636. J Pediatr Hematol Oncol. 2012. PMID: 22215099 Free PMC article.
Outcome and pathologic classification of children and adolescents with mediastinal large B-cell lymphoma treated with FAB/LMB96 mature B-NHL therapy.
Gerrard M, Waxman IM, Sposto R, Auperin A, Perkins SL, Goldman S, Harrison L, Pinkerton R, McCarthy K, Raphael M, Patte C, Cairo MS; French-American-British/Lymphome Malins de Burkitt 96 (FAB/LMB 96) International Study Committee. Gerrard M, et al. Blood. 2013 Jan 10;121(2):278-85. doi: 10.1182/blood-2012-04-422709. Epub 2012 Nov 13. Blood. 2013. PMID: 23149845 Free PMC article. Clinical Trial.
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1.
Frazer JK, Li KJ, Galardy PJ, Perkins SL, Auperin A, Anderson JR, Pinkerton R, Buxton A, Gross TG, Michon J, Leverger G, Weinstein HJ, Harrison L, Shiramizu B, Barth MJ, Goldman SC, Patte C, Cairo MS. Frazer JK, et al. Among authors: michon j. Br J Haematol. 2019 Apr;185(2):374-377. doi: 10.1111/bjh.15520. Epub 2018 Aug 16. Br J Haematol. 2019. PMID: 30117142 Free PMC article. Clinical Trial. No abstract available.
Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients.
Patte C, Auperin A, Gerrard M, Michon J, Pinkerton R, Sposto R, Weston C, Raphael M, Perkins SL, McCarthy K, Cairo MS; FAB/LMB96 International Study Committee. Patte C, et al. Among authors: michon j. Blood. 2007 Apr 1;109(7):2773-80. doi: 10.1182/blood-2006-07-036673. Blood. 2007. PMID: 17132719 Free PMC article. Clinical Trial.
Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents.
Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, Weston C, Perkins SL, Raphael M, McCarthy K, Patte C; FAB LMB96 International Study Committee. Cairo MS, et al. Among authors: michon j. Blood. 2007 Apr 1;109(7):2736-43. doi: 10.1182/blood-2006-07-036665. Blood. 2007. PMID: 17138821 Free PMC article. Clinical Trial.
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study.
Jourdain A, Auperin A, Minard-Colin V, Aladjidi N, Zsiros J, Coze C, Gandemer V, Bertrand Y, Leverger G, Bergeron C, Michon J, Patte C; SFCE LNH Committee. Jourdain A, et al. Among authors: michon j. Haematologica. 2015 Jun;100(6):810-7. doi: 10.3324/haematol.2014.121434. Epub 2015 Feb 27. Haematologica. 2015. PMID: 25724577 Free PMC article.
Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study.
Rigaud C, Auperin A, Jourdain A, Haouy S, Couec ML, Aladjidi N, Gandemer V, Lambliotte A, Plat G, Landman-Parker J, Michon J, Leblanc T, Patte C, Minard-Colin V. Rigaud C, et al. Among authors: michon j. Pediatr Blood Cancer. 2019 Sep;66(9):e27873. doi: 10.1002/pbc.27873. Epub 2019 Jun 17. Pediatr Blood Cancer. 2019. PMID: 31207026 Clinical Trial.
The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
Patte C, Auperin A, Michon J, Behrendt H, Leverger G, Frappaz D, Lutz P, Coze C, Perel Y, Raphaël M, Terrier-Lacombe MJ; Société Française d'Oncologie Pédiatrique. Patte C, et al. Among authors: michon j. Blood. 2001 Jun 1;97(11):3370-9. doi: 10.1182/blood.v97.11.3370. Blood. 2001. PMID: 11369626 Free article. Clinical Trial.
In childhood mature B-NHL with CNS disease, patients with blasts in cerebrospinal fluid are at higher risk of failure.
Simonin M, Auperin A, Bertrand Y, Aladjidi N, Baruchel A, Contet A, Coze C, Gandemer V, Haouy S, Leblanc T, Leverger G, Michon J, Patte C, Minard-Colin V. Simonin M, et al. Among authors: michon j. Blood Adv. 2020 Aug 11;4(15):3621-3625. doi: 10.1182/bloodadvances.2019001398. Blood Adv. 2020. PMID: 32766852 Free PMC article. Clinical Trial.
543 results